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Abstract
Recent evidence has implicated innate immunity in regulating neuronal survival in the brain during stroke and other
neurodegenerations. Photoreceptors are specialized light-detecting neurons in the retina that are essential for vision. In this
study, we investigated the role of the innate immunity receptor TLR4 in photoreceptors. TLR4 activation by
lipopolysaccharide (LPS) significantly reduced the survival of cultured mouse photoreceptors exposed to oxidative stress.
With respect to mechanism, TLR4 suppressed Wnt signaling, decreased phosphorylation and activation of the Wnt receptor
LRP6, and blocked the protective effect of the Wnt3a ligand. Paradoxically, TLR4 activation prior to oxidative injury
protected photoreceptors, in a phenomenon known as preconditioning. Expression of TNFa and its receptors TNFR1 and
TNFR2 decreased during preconditioning, and preconditioning was mimicked by TNFa antagonists, but was independent of
Wnt signaling. Therefore, TLR4 is a novel regulator of photoreceptor survival that acts through the Wnt and TNFa pathways.
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Introduction
Toll-like receptors (TLRs) are essential mediators of innate and
adaptive immunity in the defence against invading pathogens.
Accordingly, TLRs are highly expressed on immune cells that
have pathogen surveillance activity [1,2]. However, the detection
of TLRs on other cell types, such as neurons and glia, suggests
additional physiological functions for TLRs. TLRs in the central
nervous system (CNS) are activated by endogenous molecules
released from injured cells that act as danger signals, known as
damage-associated molecular patterns (DAMPs) [1,3,4,5]. TLR4
in particular is increasingly being recognized as a modulator of
neuronal survival in the brain during non-pathogen (sterile)
injuries [6]. TLR4 is upregulated in many neurodegenerative
diseases and neuronal injuries [7,8] and also increases when
neurons are exposed to toxic proteins and lipid peroxidation
products [9]. Excessive activation of TLR4 and other TLRs
induces expression of cytokines and pro-inflammatory molecules,
resulting in further neuronal damage [10]. Indeed, induction of
the TLR4 innate immunity pathway during oxidative and
ischemic injuries promotes severe axonal and neuronal loss
[9,11,12,13,14]. Furthermore, mice lacking TLR4 show reduced
neuronal apoptosis and decreased pathology in the retina and
brain [13,14], which lends further support for a pathologic role of
TLR4 in neuronal injury.
Paradoxically, low levels of TLR4 activation are believed to be
beneficial to the CNS, and lead to a mild immune response,
interferon production and reduced neuronal death. For example,
low doses of LPS applied prior to CNS injury decreases neuronal
damage during subsequent injury, in a phenomenon known as
preconditioning [15,16]. Therefore, precise regulation of TLR
activity plays an important, yet poorly understood, role in
neuronal injury and survival.
The Wnt pathway is an essential signaling cascade that regulates
numerous processes in embryonic and adult tissues, including
cellular proliferation, survival and differentiation. Our group and
others recently demonstrated that Wnt signaling is increased
during neuronal injury in the retina and is neuroprotective to
retinal neurons and cell lines [17,18,19,20,21]. However, endog-
enous regulators of Wnt signaling are unknown. Interestingly,
TLR4 was recently reported to down-regulate the Wnt pathway in
enterocytes in the ileum of newborn mice [22], raising the
possibility that TLR4 may regulate Wnt signaling and thereby
influence photoreceptor survival.
Photoreceptors are light-sensing cells in the retina, which is the
thin, multi-layer tissue at the back of the eye that is essential for
vision. In the present study, we investigated the consequences of
TLR4 activation on photoreceptor survival and tested whether
TLR4 modulates the neuroprotective property of Wnt signaling.
In summary, our findings show that TLR4 reduced photoreceptor
survival in the presence of oxidative stress. Additionally, TLR4
suppressed Wnt-dependent protection of photoreceptors, and
decreased phosphorylation of the Wnt pathway mediator LRP6
but not GSK3b. Furthermore, TLR4 activation prior to oxidative
stress protected photoreceptors, and this preconditioning effect
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involved TNFa and was not dependent on Wnt signaling. Because
damage and death of photoreceptors is a major cause of retinal
degeneration diseases, our results implicate TLR4 in regulating
photoreceptor death during retinal degeneration by interfering
with the neuroprotective activity of Wnt signaling.
Results
TLR4 is Expressed in Muller Glia and Photoreceptors
Muller glia are the major radial glia type in the retina that
provides trophic support to photoreceptors. Photoreceptor survival
is influenced by proteins within the photoreceptors themselves as
well as proteins secreted from adjacent Muller glia. We first
examined whether TLR4 was expressed in these relevant cell
types, using immunohistochemistry on dissociated Muller glia-
photoreceptor co-cultures. The co-cultures are enriched (.99%)
for Muller glia and photoreceptors, as previously described in [17],
and offer the advantage of eliminating the contribution of other
TLR4-responsive cells, such as microglia and astrocytes.
TLR4 was detected in both Muller glia and photoreceptors, as
shown in Figure 1. Immunostaining for TLR4 overlapped with
rhodopsin-positive photoreceptors and vimentin-positive Muller
glia (Figure 1A). TLR4 expression in primary Muller glia culture
and the Muller glia cell line MIO-M1 was confirmed by Western
blotting (Figure 1B–C) and PCR (Figure 1D–E). The specificity of
the anti-TLR4 antibody was indicated by the disappearance of the
100 kDa TLR4 band after preincubating the antibody with the
peptide used to create the antisera (Figure 1C). Also, the TLR4
activator LPS induced a dose-dependent increase in the target
gene IL6 in a Muller glia cell line, providing functional evidence of
TLR4 activity in glia (Figure 1E).
To further confirm that TLR4 is functional in the Muller glia-
photoreceptor primary co-cultures, we quantified nuclear locali-
zation of p65/RELA, a downstream target of TLR4 through the
NFkB pathway. Upon TLR4 activation, the NFkB/p65 complex is
liberated from its inhibitor in the cytoplasm and translocates into
the nucleus where it activates transcription. Nuclear p65 is often
used as a marker of TLR4 activity [23]. The function of TLR4 in
response to LPS treatment was examined in the Muller glia
because Muller glia are a primary source of growth factors in the
retina and have been shown to increase photoreceptor viability
during injury through Wnt signaling [17]. The Muller glia-
photoreceptor cultures showed a significant increase in nuclear
localized p65 in glutamine synthetase-positive Muller glia after
treatment with LPS (Figure 2A–B, p,0.001, n = 5). LPS also
induced a dose-dependent increase in nuclear localization of p65
in the Muller glia cell line MIO-M1 (Figure 2C–D, p,0.01, n = 5).
These data demonstrate that the primary cultures are an
appropriate in vitro model to investigate the role of TRL4 in
photoreceptors and Muller glia in response to LPS stimulation.
Activation of TLR4 Decreases Photoreceptor Survival
The expression of TLR4 in Muller glia and photoreceptors led
us to ask what is its potential role in photoreceptor survival. The
Muller glia-photoreceptor primary co-cultures were used to test
the effect of TLR4 activation on photoreceptor viability. The co-
cultures reflect the response of only the two cell types of interest,
Muller glia and photoreceptors, and have been used previously to
investigate mechanisms of photoreceptor survival in many studies,
particularly when fewer cell types and absence of systemic factors
are preferred [24,25]. The TLR4-responsive microglia cell type
represents fewer than 0.005% of the cells in the culture, as
detected by an antibody against the IBA-1 protein [17].
H2O2, a commonly used inducer of oxidative stress, was used
to injure the photoreceptors. Oxidative stress was chosen
because it is a key contributor to photoreceptor death in vivo
[26]. Previous studies with this experimental design demonstrat-
ed that photoreceptors were susceptible to H2O2 (99% of dead
cells) and not Muller glia (1%), and showed that Wnt3a
protected photoreceptors from H2O2-induced death [17]. Muller
glia-photoreceptor co-cultures were incubated in 0.4 mM H2O2
in the presence or absence of recombinant Wnt3a and LPS.
The prototypic ligand LPS was used to activate TLR4 in these
experiments because the endogenous activators of TLR4 in the
retina are unknown. As shown in Figure 3A, LPS significantly
reduced photoreceptor survival in the presence of H2O2
whereas Wnt3a was protective (p,0.05 vs H2O2 alone, n= 4).
Furthermore, the combination of LPS and Wnt3a with H2O2
had lower survival than Wnt3a with H2O2, indicating that LPS
reduced the protective effect of Wnt3a (p,0.05 vs Wnt3a,
n = 4). LPS is not toxic in the absence of H2O2, indicating
a requirement for injury (see Figure 3C).
To confirm that LPS induced photoreceptor apoptosis, we
quantified the number of cells in which we detected both active
caspase 3 and the photoreceptor marker rhodopsin. Label overlap
(*) of rhodopsin-positive photoreceptors (green) with active caspase
3 (red) marks photoreceptors dying from H2O2 (Figure 3B). No
label overlap was observed with the Muller glia marker vimentin
and active caspase 3, indicating resistance to H2O2 (not shown).
Quantification of overlap indicates that Wnt3a reduced the
percent of activated caspase 3-positive photoreceptors consistent
with the viability assay above (compare no additions vs. Wnt3a,
Figure 3C) (p,0.05, n= 5 for no additions and n= 4 for Wnt3a).
Furthermore, LPS prevented Wnt3a-mediated protection and
increased the percent of caspase-positive photoreceptors (compare
Wnt3a vs. 50 mg/ml LPS+Wnt3a) (Figure 3C, p,0.05, n= 4 for
Wnt3a and n= 5 for 50 mg/ml LPS+Wnt3a). LPS did not increase
the amount of caspase-positive photoreceptors in the absence of
H2O2 (Figure 3C).
Next, we investigated whether blocking endogenous TLR4
activity affects photoreceptor survival. LPS-RS is a potent
antagonist of TLR4 that competes with LPS for binding to
myeloid differentiation protein 2 (MD-2) [27], and the MyD88
homodimerization inhibitory peptide blocks TLR activity by
acting as a decoy by binding to the MyD88 TIR domain. The
Muller glia-photoreceptor cultures were injured by H2O2 in the
presence of LPS-RS or MyD88 inhibitor peptide, and photo-
receptor survival was measured. LPS was not included in these
experiments to allow testing of the effects of endogenous
activation of TLR4 on photoreceptor viability. Both LPS-RS
and the MyD88 inhibitor significantly increased survival
(Figure 3D, p,0.05, n= 3), indicating that blocking endogenous
TLR4 activation protects against oxidative-stress induced cell
death.
Activation of TLR4 Decreases Neuroprotective Wnt
Signaling
The viability results described above led us to investigate the
relationship between TLR4 and Wnt signaling. Because Muller
glia express both Wnt receptors and TLR4, and Wnt signaling
protects photoreceptors against oxidative stress (Figure 3, [17]), we
hypothesized that TLR4 activity contributes to photoreceptor
death by suppressing the Wnt pathway in Muller glia during
oxidative stress. To test the effect of TLR4 on Wnt signaling,
Muller glia-photoreceptor co-cultures were cotreated with LPS
and Wnt3a, or treated with Wnt3a alone. As shown in Fig. 4A,
LPS resulted in a modest but significant decrease of Wnt signaling,
TLR4 Regulates Wnt-Mediated Photoreceptor Survival
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by 21% (p,0.05, n = 3) in H2O2-injured Muller glia-photorecep-
tor co-cultures, as measured by Wnt signaling luciferase reporter
assays.
Wnt3a increases Wnt signaling only in the Muller glia in the co-
cultures because photoreceptors do not show active Wnt signaling
pathways [17]. Therefore, a Muller glia cell line was used to
further explore the relationship between TLR4 and Wnt signaling.
The MIO-M1 Muller glia cell line offers the advantage of higher
transfection efficiencies and larger cell numbers than the primary
cultures. Treatment of MIO-M1 cells with increasing concentra-
tions of LPS (0.5–50 mg/ml) resulted in dose-dependent suppres-
sion of Wnt3a-mediated Wnt signaling (Figure 4B, p,0.05, n= 3).
Figure 1. Expression of TLR4 in primary Muller glia-photoreceptor co-cultures. (A) TLR4 (red) is expressed in rhodopsin-positive
photoreceptors (green). DAPI marks the nuclei. Detection of TLR4 and rhodopsin in the same photoreceptor cell is indicated by label overlap and is
shown in the merged image. TLR4 (red) was also detected in vimentin-positive Muller glia (green). No antibody control indicates absence of non-
specific immunostaining. Confocal microscopy, 636. Scale bar is 20 mm. (B) Western blot showing detection of TLR4 protein (arrow) in whole cell
lysates from the Muller glia cell line MIO-M1 (MG). The microglia cell line BV-2 was used as a positive control (mg). MWT, molecular weight marker,
with sizes indicated on the left. (C) The specificity of the anti-TLR4 antibody was confirmed by preincubating with its peptide epitope. Detection of
the TLR4 protein was evident with the antibody alone (Ab) but was mostly eliminated by 100 mg of the peptide antigen (Ab+pep1), and entirely
eliminated by 200 mg (Ab+pep2). (D) TLR4 was detected by RT-PCR from primary cultures of Muller glia. Lane 1, diluted cDNA; lane 2, undiluted cDNA;
lane 3, no template control. Lack of signal in the control indicates the specificity of the PCR reaction. (E) Dose-dependent induction of the TLR4 target
gene IL-6 by LPS demonstrates that TLR4 is functional in the Muller glia cell line MIO-M1. IL-6 expression was measured by QPCR, and normalized to
the house-keeping gene ARP. Mean 6 SD, *p,0.05, n = 4, compared with untreated UT.
doi:10.1371/journal.pone.0036560.g001
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To confirm that TLR4 mediated the LPS-dependent suppression
of Wnt signaling, the cultures were transfected with wild-type
TLR4 or a functionally inactive dominant-negative TLR4 mutant
(dnTLR4). The dnTLR4 gene contains the inhibitory P712H
mutation, is unresponsive to LPS and blocks endogenous LPS/
TLR4 signaling [28,29]. Transfection of dnTLR4 did not suppress
Wnt signaling in the presence of LPS, and resulted in the same
level of luciferase activity as the EGFP control gene (Figure 4C). In
contrast, Wnt signaling was suppressed by wild-type TLR4 by
40% (Figure 4C, p,0.05, n = 5). Expression of TLR4 without
added LPS also led to decreased Wnt signaling, consistent with
TLR4 over-expression activating its pathway without exogenous
ligands and providing additional evidence that TLR4 inhibits Wnt
signaling.
Quantitation of the TLR4 target gene IL6 confirmed that
dnTLR4 was unresponsive to LPS, that wild-type TLR4 was
stimulated by LPS, and that wild-type TLR4 could also function
independently of LPS addition (Figure S1, p,0.01, n= 4).
Together, the data in Figures 3 and 4 suggest that the molecular
basis for decreased viability of the Muller glia-photoreceptor
primary cultures co-treated with LPS and Wnt3a is due to TLR4
decreasing Wnt signaling and reducing Wnt3a-mediated pro-
tection against H2O2.
TLR4 Regulates the Wnt Pathway through LRP6
We next examined the mechanism by which TLR4 reduced
Wnt3a-induced signaling. In the canonical Wnt pathway, Wnt
ligands bind to Frizzled and LRP5/6 co-receptors at the plasma
membrane, leading to recruitment of axin to the membrane and
stabilization of the central mediator b-catenin [30,31]. Phosphor-
ylation of LRP6 at positions Ser1490, Thr1479 and Thr1493 is an
important early activation step of the canonical Wnt pathway [32].
LRP6 phosphorylation at Ser1490 was measured in Muller glia
MIO-M1 cells after Wnt3a addition in the presence or absence of
50 mg/ml LPS. Addition of Wnt3a lead to a 3.9-fold increase in
phospho-LRP6 compared with control when tested after 1 hr,
2 hr and 4 hr, but not at 24 hr (Figure 5A–B, results for 1 hr are
shown). However, LPS decreased phospho-LRP6 by approxi-
mately 50% (Figure 5A–B, p,0.05, n = 6). Therefore, TLR4
activation by LPS interrupts Wnt signaling at an early point in the
pathway.
The phosphorylation status of the Wnt pathway intermediate
GSK3b at position Ser 9 was also examined. GSK3b is a critical
inhibitor of the Wnt pathway that plays a central role in the
‘‘destruction complex’’ that maintains low levels of b-catenin [31].
Thus, decreased phosphorylation of GSK3b is often associated
with enhanced Wnt pathway activation. Muller glia MIO-M1 cells
treated with Wnt3a showed a small reduction in GSK3b
Figure 2. TLR4 is functional in primary Muller glia-photoreceptor co-cultures and a Muller glia cell line. (A) Nuclear translocation of the
downstream TLR4 effector p65 was used as a marker of TLR4 activation. Muller glia-photoreceptor cultures treated with LPS (5 mg/ml) show nuclear
localized p65 in Muller glia, as shown by p65 detection in the nuclei of cells costaining with the Muller glia marker glutamine synthetase (GS,
asterisks). The arrowheads indicate GS-positive cells that contain cytoplasmic p65, indicating lack of TLR4 activation. Neg, immunostaining negative
control. (B) Quantification of cells with p65 signal that overlapped with DAPI stained nuclei in glutamine synthetase-positive Muller glia. Mean 6 SD,
***, p,0.001, n = 5. (C–D) MIO-M1 cells treated with LPS also show nuclear p65 (*) compared with untreated cells (UT). Dose-dependent nuclear
translocation of p65 by LPS, indicating TLR4 activation in the Muller glia cell line. Mean 6 SD, **, p,0.01, n = 5. Scale bar in (A) is 10 mm.
doi:10.1371/journal.pone.0036560.g002
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phosphorylation on Ser 9 compared with control, which did not
reach statistical significance (Figure 5C). Co-treating the cells with
Wnt3a and LPS also did not result in significant changes in
GSK3b phosphorylation when tested after 1 hr, 2 hr and 4 hr
(results for 1 hr shown). Therefore, TLR4 activation is unlikely to
suppress Wnt signaling by regulating GSK3b activity through Ser9
phosphorylation. The luciferase assays and LRP6 analysis together
demonstrate that activation of TLR4 suppresses Wnt signaling in
Muller glia cells.
Preconditioning by TLR4 Protects Photoreceptors
Preconditioning occurs when exposure to low levels of an
otherwise harmful stimulus protects against subsequent exposure
to toxic levels of the same or different stimulus [15,16].
Importantly, preconditioning by one stimulus can often induce
tolerance to other types of injury and preconditioning by LPS has
been demonstrated to protect against ischemia in the CNS and
other tissues, raising the possibility that LPS-dependent precondi-
tioning may protect photoreceptors against oxidative stress [33].
To test whether TLR4 activation by LPS induces a precondi-
tioning response in the Muller glia-photoreceptor co-cultures, we
stimulated TLR4 by adding LPS 2 hours prior to exposure to
oxidative stress, and photoreceptor viability was measured after an
additional 24 hours. There was significant protection from cell
death observed with 0.5 and 5 mg/ml LPS compared with cultures
that did not receive LPS (Figure 6A, p,0.05, n= 4). Treatment
with Wnt3a (150 ng/ml) also protected photoreceptors, as
observed in Figure 3 and Yi et al. [17], and the combination of
Wnt3a and LPS-induced preconditioning had greater protection
than Wnt3a alone, suggesting an additive effect (Figure 6B,
p,0.05, compared with Wnt3a, n= 4). Therefore, in contrast to
the damaging effect of TLR4 activation during injury (Figure 3),
Figure 3. The TLR4 activator LPS decreases photoreceptor viability and reducesWnt-mediated protection from oxidative stress. (A)
Muller glia-photoreceptor cultures were incubated for 24 hr in 0.4 mM H2O2 to induce oxidative stress, with and without recombinant Wnt3a
(150 ng/ml) or the TLR4 activator LPS (5 and 50 mg/ml). Viability was measured by Cell Titer Blue. (A) LPS significantly reduced photoreceptor survival
in the presence of H2O2 whereas Wnt3a is protective (*p,0.05 vs H2O2 alone). Furthermore, LPS reduced the protective effect of Wnt3a (#p,0.05 vs
Wnt3a). Mean 6 SEM, n= 4. (B) Confirmation that LPS blocks Wnt3a rescue of photoreceptors. Active caspase 3 (red) marks rhodopsin-positive
photoreceptors (green) photoreceptors dying from H2O2. *, represents label overlap, indicating the proteins are detected in the same cell. Confocal
microscopy, 636, n = 4. (C) Quantification of overlap indicates that Wnt3a reduced the number of caspase-positive photoreceptors and LPS decreased
Wnt3a protection. LPS is not toxic in the absence of H2O2. White bars, no H2O2; black bars, with H2O2. Mean 6 SD, *p,0.05 no additions with H2O2
(n = 5) compared with Wnt3a (n = 4); #p,0.05 50 mg/ml LPS+Wnt3a (n = 5) compared with Wnt3a+ H2O2 (n = 4). (D) Retina cultures were incubated
with LPS-RS (5 mg/mL) and the MyD88 inhibitor decoy peptide (0.5 mM) to block endogenous TLR4 activity, and cell viability in response to H2O2
injury was measured as above. Viability was measured by Cell Titer Blue and was normalized to the respective controls (PBS for LPS-RS, control
peptide for MyD88 inhibitor). The inhibitors significantly increased viability. Mean 6 SD, *p,0.05, n = 3.
doi:10.1371/journal.pone.0036560.g003
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preconditioning by TLR4 activation by LPS prior to an injury
resulted in increased photoreceptor viability. Indeed, the impor-
tance of the timing of LPS treatment relative to injury is shown
using the 5.0 mg/ml dose, which is toxic when LPS is cotreated
with H2O2 but is protective when added 2 hr before H2O2. LPS-
induced tolerance is usually a lower dose than the toxic dose [16],
which is also shown in our results because preconditioning was
significant with 0.5 mg/ml LPS whereas 5.0 mg/ml was required
for toxicity to photoreceptors.
To investigate the mechanism of preconditioning, we first
examined expression of candidate mediators downstream of TLR4
activation to determine whether there was a correlation between
expression changes and increased photoreceptor survival. TNFa
expression was significantly increased in the LPS-treated cultures
compared with untreated cultures (Figure 7A), consistent with it
being a downstream target of LPS. The expression of TNFa
receptors TNFR1 and TNFR2, which are also targets of LPS,
showed a mild, but not statistically significant, increase in the LPS-
treated cultures (Figure 7A). In contrast, in preconditioned cultures
(LPS+ H2O2), expression of TNFa was 2.3 fold lower than LPS-
treated retinal cultures in the absence of H2O2 (p,0.05, n = 3).
Similarly, the receptors TNFR1 and TNFR2 were 2-fold and 1.7-
fold lower in the preconditioned cultures, respectively, compared
with LPS treatment alone. Therefore, these data suggest that
decreased TNFa signaling is associated with photoreceptor
preconditioning to H2O2.
We next investigated whether TNFa signaling plays a role in
LPS-induced preconditioning. If preconditioning requires reduced
TNFa signaling, then suppressing the TNFa pathway further is
expected to enhance the protective activity of LPS. First, an anti-
TNFa blocking antibody was used to inhibit the activity of
endogenous TNFa. As shown in Figure 7B, the viability of
photoreceptors treated with a combination of anti-TNFa antibody
and LPS was over 2-fold higher than LPS cotreated with the IgG
control (Figure 7B, p,0.05, n= 6). The anti-TNFa antibody alone
showed photoreceptor protection, indicating that it was able to
substitute for LPS. Additionally, the viability of photoreceptors was
significantly increased by inhibitors of the TNFR1 and TNFR2
receptors (50 ng/ml) in the absence of LPS (Figure 7C, p,0.05,
n = 6). The protection by the combination of TNFR1 and TNFR2
inhibitors was equivalent to both added separately, indicating their
protective effect was not additive. Treating the cultures with
TNFR1 and TNFR1 inhibitors in combination with LPS did not
enhance preconditioning more than LPS alone, suggesting
a maximum level of protection was achieved by LPS (Figure 7C).
The addition of recombinant TNFa (5 ng/ml) reduced photore-
ceptor viability to the level of the PBS control, which was reversed
by TNFR1 and TNFR1 inhibitors (p,0.05, n = 6), indicating their
effectiveness.
Wnt signaling reporter assays were used to determine whether
preconditioning is associated with Wnt signaling. Cultures treated
with recombinant Wnt3a showed Wnt signaling induction, as
expected (Figure 8A, p,0.05, n = 5). However, Wnt signaling in
LPS-induced preconditioned cultures (LPS+ H2O2) was not higher
than H2O2 alone, and the preconditioned cultures in the presence
of Wnt3a (Wnt3a+ LPS+ H2O2) was also not significantly different
Figure 4. Potential mechanism of photoreceptor death: TLR4 suppresses neuroprotective Wnt signaling. The TLR4 activator LPS
significantly decreased Wnt signaling in Muller glia-photoreceptor cultures (A) and the Muller glia cell line MIO-M1 (B–C), as measured by luciferase
reporter assay. Normalization to cotransfected Renilla was used to account for the effect of LPS reducing cell number (*p,0.01, n = 4). (C) Wnt
signaling is suppressed by wild-type TLR4 (white bars) but not dominant-negative (grey bars) (*p,0.05, n = 5). Luciferase activity was normalized to
cotransfected Renilla luciferase, and is shown as the ratio of Wnt signaling in Wnt3a-treated cells to control-treated cells. Mean + SD is shown.
doi:10.1371/journal.pone.0036560.g004
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than non-preconditioned cultures (Wnt3a+H2O2) (Figure 8A),
despite Wnt3a+LPS+ H2O2 having significantly greater viability
than Wnt3a+ H2O2 (Figure 6B). Therefore, LPS-induced pro-
tective preconditioning does not depend on Wnt3a-induced
survival pathways. This result contrasts with LPS-induced toxicity,
which was associated with suppressed Wnt signaling (see Figure 4).
To test whether inhibiting endogenous Wnt signaling would
reduce LPS-induced preconditioning, the Muller glia-photorecep-
tor co-cultures were incubated with LPS combined with 200 ng/
ml of the Wnt pathway inhibitor Dkk1, followed by exposure to
H2O2 to induce injury. As shown in Figure 8B, Dkk1 did not
significantly change the viability of the cultures compared with
LPS alone, confirming that preconditioning occurs without
endogenous Wnt pathway activation. A proposed model de-
scribing the regulation of photoreceptor neuroprotection by cross-
talk between TLR4 and Wnt signaling pathways, as derived from
our experiments, is shown in Figure 8C.
TLR4 Distribution in a Mouse Model of Retinal
Degeneration
We next analyzed the expression pattern of TLR4 in retinas
with photoreceptor degeneration to determine whether TLR4 is
expressed in photoreceptors and Muller glia in vivo. The C57Bl/6
mouse was used as a wild-type control, an antibody against
rhodopsin was used to identify rod photoreceptors, and an
antibody that detects vimentin was used to identify Muller glia.
In the C57Bl/6 retina, there was prominent TLR4 immunostain-
ing in rhodopsin-positive photoreceptors, which was localized in
the region corresponding to photoreceptor inner segments (arrows
in Figure 9A). TLR4 immunodetection also overlapped with
vimentin-positive cellular extensions, indicating TLR4 expression
in Muller glia (Figure 9B). This expression pattern is consistent
with our findings in the Muller glia-photoreceptor co-cultures
(Figure 1). The specificity of the anti-TLR4 antibody was
confirmed by lack of signal in TLR4 knock-out mice (Figure S2)
and by lack of TLR4 immunodetection in the no primary antibody
negative controls (Figure 9A–D). Signal overlap analysis is shown
in Figure S3.
Next, the expression of TLR4 during photoreceptor death was
analyzed using the C3H/HeOuJ mouse model of retinal de-
generation (also known as rd1). The rd1 strain carries the retinal
degeneration allele Pde6brd1 and the wild-type TLR4 allele
[28,34,35] and exhibits rapid rod photoreceptor death. The
retinas were analyzed at post-natal day 14, which corresponds to
the peak of rod photoreceptor death. The thickness of the outer
nuclear layer and the number of rows of photoreceptor nuclei in
the outer nuclear layer was reduced in the rd1 retina due to death
of the rod photoreceptors (Figure 9C–D). TLR4 was located in the
photoreceptor inner segments in the rd1 retina, similar to wild-type
retina, and was also prominently detected in the Muller glia
(Figure 9C–D). Furthermore, the distribution of TLR4 in the
photoreceptor layer changed during retinal degeneration and it
became detectable in the outer nuclear layer, where the
photoreceptor soma and nuclei are located (Figure 9C, Figure
S2B). The new localization of TLR4 is similar to rhodopsin, which
also becomes localized to the ONL, and may be due to a general
mislocalization of proteins that occurs when the photoreceptor
outer segments degenerate. TLR4 was not located in the outer
nuclear layer in the age-matched wild-type mouse retina
Figure 5. TLR4 decreases Wnt signaling at the level of the LRP6 receptor activation in Muller glia MIO-M1 cells. (A) Representative
Western blots showing changes in phosphorylation status with Wnt signaling and LPS. Wnt3a conditioned media (W) increases the levels of phospho-
Ser1490 LRP6 (p-LRP6) compared with control conditioned media (C). The addition of LPS reduces p-LRPS in Wnt3a treated cultures. In contrast, the
amount of phospho-Ser9 in GSK3b is not affected by LPS. (B–C) Quantification of phospho-LRP6 and phospho-GSK3b. Twenty micrograms of total
protein were loaded in each lane. The phosphorylated proteins were detected by phospho-specific antibodies and normalized to b-actin as a labeled
control, and total LRP6 and GSK3b proteins were detected by antibodies that recognize both their respective phospho- and unphosphorylated forms,
and normalized to b-actin. #, Wnt3a compared with control p,0.05, n = 5; *, Wnt3a compared with Wnt3a+LPS p,0.05, n = 5.
doi:10.1371/journal.pone.0036560.g005
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(Figure 9A, Figure S2A). Therefore, TLR4 is localized to
photoreceptors and Muller glia in wild-type and degenerating
mouse retinas, similar to its localization in the primary co-cultures,
suggesting that TLR4 is a potential candidate regulator of
photoreceptor death in vivo.
Discussion
In this study, we showed that activation of the innate immunity
TLR4 receptor has a dual role in regulating photoreceptor
survival. TLR4 activation in the presence of oxidative stress
reduced photoreceptor survival, whereas stimulation of TLR4
prior to injury increased photoreceptor survival, in a phenomenon
known as preconditioning. The mechanism of TLR4 toxicity
involved suppression of Wnt-dependent photoreceptor rescue,
whereas TLR4-dependent preconditioning involved suppression
of TNFa activity. Therefore, TLR4 is an important regulator of
photoreceptor viability in culture, and may be an important
element in the pathogenesis of retinal diseases where inflammation
is a factor.
Our results are consistent with previous findings showing a toxic
role for TLR4 in the CNS [9,10,11,12,13,14]. Ko et al. (2011) also
found that TLR4 activation, in this case by subcutaneous injection
of heat killed M. tuberculosis, induced oxidative damage to
photoreceptor outer segments, which was associated with elevated
photoreceptor death and increased TNFa expression [36]. In
contrast, LPS increased viability of the photoreceptor cell line
661 W when coapplied with injury induced by the nitrous oxide
donor SNP [37]. Studies using animal models indicated that
excessive TLR4 signaling and induction of innate immunity
pathways contribute to further tissue damage by promoting axonal
damage and neuronal death from oxidative and ischemic injuries
[9,11,12,13,14]. In CNS damage models, mice lacking TLR4 have
smaller infarct sizes, lower TNFa, IL6 and NFkB, and better
outcomes in neurological and behavioral assays [7,14]. Also, lack
of TLR4 improved survival of retinal ganglion cells from axotomy-
induced death [13]. Therefore, the majority of studies point to
a pathologic activity of TLR4 in the brain and retina during
neuronal injury.
Although LPS was used to activate TLR4 in this study, TLR4 in
neurons and astrocytes is believed to be activated during CNS
damage by DAMPs that are passively released from injured cells,
such as hsp70 [38], hyaluronic acid [39] and high-mobility group
protein box-1 (HMGB1) [40,41,42]. TLR4 activation leads to the
release of TNFa, interleukin-1b, and other cytokines, which
exacerbates the inflammatory response [43]. DAMPs also induce
downstream pathways involved in regeneration [44] and neurite
outgrowth [45], thereby stimulating tissue repair. Several endog-
enous TLR4 activators are upregulated during photoreceptor
oxidative injury in vivo, such as HMGB1 [40,46], suggesting that
they may be a source of TLR4 activation during retinal disease.
Regarding a mechanism of TLR4-mediated toxicity, our study
is the first example of an innate immunity receptor regulating the
neuroprotective Wnt signaling pathway in the CNS. Because Wnt
signaling induces growth factors in Muller glia [47], a potential
mechanism for TLR4-induced photoreceptor death is by TLR4
activation suppressing Wnt signaling, leading to reduced growth
factor expression and secretion, and increased photoreceptor
death in response to oxidative stress. However, other mechanisms
of TLR4 mediated death may also be involved that are
independent from reduced Wnt signaling, including a direct effect
of TLR4 on MAPK, NFkB and Jak1/Stat1 signaling pathways
[48,49]. TLR4 has also been shown to mediate neuronal toxicity
through caspase 3, neuronal iNOS and phosphorylation of the
stress kinases ERK1/2, JNK1/2 and p38 [13].
In support of our findings for an interaction between TLR4 and
Wnt pathways, Sodhi et al. demonstrated that TLR4 activation
decreased b-catenin levels in enterocytes in a mouse model of
necrotizing endocolitis (NEC) [22]. Whereas we found that TLR4
suppressed Wnt signaling in Muller glia by reducing phosphory-
lation and therefore activation of LRP6, TLR4 acted further
downstream in enterocytes by increasing GSK3b activity via
regulation of AKT [22]. Reduced Wnt signaling is believed to be
a factor in impaired enterocyte proliferation in NEC, and
inhibiting TLR4 restored Wnt signaling and rescued the
enterocyte phenotype. Interestingly, TLR4 activation in different
cell types in the intestine can lead to opposite effects on enterocyte
proliferation, possibly due to cell-specific effects, age of the animal
and extent and duration of inflammation [22]. Also, LPS reduced
nuclear b-catenin levels and Wnt luciferase reporter activity in an
osteoblast cell line [50]. However, in Drosophila, Toll/NFkB
signaling upregulated the b-catenin-independent Wnt family
member WntD [51], possibly indicating species-specific and
context-dependent effects.
Innate immunity in the retina is typically mediated by the
immune-regulator cells microglia and astrocytes, although TLR4
Figure 6. Preconditioning by LPS-induced TLR4 activation
protects photoreceptors from oxidative stress. (A) Muller glia-
photoreceptor cultures were incubated in LPS (0.05–50 mg/ml) two hrs
before challenge with 0.4 mM H2O2. Significant protection was seen
with 0.5 and 5 mg/ml LPS (*p,0.05 vs no LPS). Mean 6 SD, n = 4. (B)
Wnt3a (150 ng/ml) also protected photoreceptors (*p,0.05 compared
with no additions). The combination of Wnt3a and 0.5 and 5 mg/ml LPS
preconditioning had greater protection than Wnt3a alone (#p,0.05 vs
Wnt3a). Mean 6 SD, n = 4. The comparison between Wnt3a+5 mg/ml
LPS vs Wnt3a+50 mg/ml LPS, Wnt3a+0.5 mg/ml LPS vs Wnt3a+5 mg/ml
LPS, and Wnt3a+50 mg/ml LPS vs no additions, are also significant at
p,0.05. Viability was measured by Cell Titer Blue.
doi:10.1371/journal.pone.0036560.g006
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is also active on non-immune cells, including RPE, Muller glia and
retinal neurons (the present study, [52,53]). Neurons throughout
the CNS are able to regulate the immune response, enabling them
to engage immune receptors in non-pathogen/stress response
situations in order to maintain homeostasis and recover from
injury. For example, in an ischemic stroke model, neurons were
the first cell types to induce TLRs, followed by increased
expression in the infiltrating microglia [7]. TLR4 localized in
photoreceptors and Muller glia may permit a more direct and
immediate response to genetic or environmental injury compared
with activation in microglia, and may also engage different
signaling pathways. TLR4 expression on photoreceptors has been
demonstrated early in development [54] and by transcript analysis
of laser microdissected photoreceptors [37]. TLRs, including
TLR4, mediate RPE phagocytosis of photoreceptor outer
segments [52]. TLR4 activation in microglia also contributes to
photoreceptor survival, because Ko et al. found that TLR4 in
microglia led to photoreceptor death after injection of heat killed
M. tuberculosis [36]. Understanding how the TLR response in the
different cells culminates in the overall retina response to injury
will be important for determining therapeutic application of TLR
pathways.
Muller glia are the principle supportive glia in the retina that are
stimulated in retinal degenerations as part of the intrinsic tissue
response to injury [55,56]. Important insights into retinal diseases
will be gained from understanding how the Muller glia-mediated
inflammatory response in the retina is regulated by genetic injury
and normal aging, and the role of endogenous regulator proteins
in suppressing innate immunity and inflammation. Our findings
also indicate that Muller glia may be cellular mediators of
photoreceptor viability in response to TLR4, in addition to any
possible direct effects of TLR4 activation on photoreceptor
viability, which have yet to be determined. Activated Muller glia
are believed to secrete growth factors that protect photoreceptors
from further damage [57,58] [47,59]. Furthermore, Muller glia-
microglia interactions may regulate the overall protection response
[56], and Muller glia also suppress the immune system [60], which
could be relevant to reducing further injury in the retina.
To our knowledge, our findings are the first to demonstrate
LPS-induced photoreceptor preconditioning, raising the possi-
Figure 7. LPS-induced preconditioning involves TNFa signaling. (A) Primary Muller glia-photoreceptor cultures were treated with 5 mg/mL
LPS 2 hr prior to 0.4 mM H2O2 and expression of TNFa and its receptors were analyzed by QPCR. The preconditioned cultures (LPS+H2O2) have lower
expression of TNFa and the receptors TNFR1 and TNFR2 (mean6 SEM, *p,0.05, n = 4). (B) Muller glia-photoreceptor cultures were treated with 5 mg/
ml anti-TNFa blocking antibody, or the IgG control, with or without LPS, 2 hr prior to H2O2 injury. Photoreceptor viability was measured and
normalized to PBS treated cultures. The viability of photoreceptors treated with a combination of anti-TNFa antibody and LPS was over 2-fold higher
than LPS cotreated with the IgG control (p,0.05, n = 6). Anti- TNFa antibody alone also showed photoreceptor protection, indicating that it
substitutes for LPS. Viability was measured by Cell Titer Blue. (C) Muller glia-photoreceptor co-cultures were treated with 50 ng/ml of the TNFR1 and
TNFR2 receptor inhibitors, with or without LPS, 2 hr prior to H2O2 injury. The TNFR1 and TNFR2 inhibitors protected the retina cultures, separately
and in combination (*p,0.05, n = 6). Treating the cultures with TNFR1 and R2 inhibitors in combination with LPS did not enhance preconditioning
more than LPS alone, suggesting a maximum level of protection was achieved by LPS. The addition of recombinant TNFa (5 ng/ml) resulted in
photoreceptor viability equivalent to PBS control, which was reversed by TNFR1 and R2 inhibitors (#p,0.05, n = 6), indicating their effectiveness.
Viability was measured by Cell Titer Blue andwas normalized to PBS treatments.
doi:10.1371/journal.pone.0036560.g007
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bility that preconditioning by LPS may protect photoreceptors
in vivo, as has been shown with preconditioning induced by
bright light [61] and hypoxia/ischemia [62]. LPS injection also
protected the inner retina (primarily retinal ganglion cells) from
elevated pressure induced by ischemia-reperfusion injury, in an
iNOS-dependent mechanism [15]. Although the physiological
correlate of LPS-induced preconditioning is not yet known, it
may indicate a role for TLR4 acting as a sensor of tissue injury
by binding to molecules released from damaged cells, degrada-
tion of the extracellular matrix and changes in cellular redox
state [1]. Injured neurons secrete TLR4 activating DAMP
molecules that stimulate microglia and other cells, potentially
Muller glia, and may induce neuroprotective cytokines and
growth factors without engaging acute inflammation and
neurotoxicity [63].
The mechanism of preconditioning by TLR4 activation is
believed to be induction of a mild inflammatory response
[15,64,65]. Our findings are consistent with this idea because
TLR4 preconditioning in photoreceptor cultures involved lower
TNFa levels than TLR4 activation in the absence of injury.
Whether TNFa is acting directly on photoreceptors or indirectly
through Muller glia remains to be established. TNFa plays dual
roles in the CNS and is a major mediator of neuroinflammation
and toxicity yet can also confer neuroprotection, depending on the
specific receptor and adapter proteins engaged [66]. Indeed, LPS-
induced preconditioning in a rat model of stroke required
upregulated TNFa and neuroprotective molecules [67–68].
However, TNFa in the retina is primarily neurotoxic. TNFa in
the vitreous is elevated during retinal degeneration and TNFa
blockers protect photoreceptors from degeneration in a retinal
detachment model [69,70]. We also showed that preconditioning
involved a distinct pathway from Wnt signaling-dependent
protection. Similarly, Barandon et al. found that ischemic
preconditioning in the mouse heart did not alter b-catenin levels
[71]. However, Brandon et al did implicate GSK3b in
preconditioning, suggesting that b-catenin independent/non-
canonical Wnt signaling may be a factor in ischemia precondition-
ing protection in the heart [71]. Therefore, the involvement of
non-canonical Wnt signaling in preconditioning in the retina is
a possibility.
Our work suggests a model in which photoreceptor injury leads
to activation of the innate immunity receptor TLR4, which
increases photoreceptor death by inhibiting Wnt signaling in
Muller glia. In contrast, TLR4-mediated preconditioning via
Figure 8. Preconditioning by LPS does not require canonical Wnt signaling. (A) Wnt signaling was measured in preconditioned Muller glia-
photoreceptor cultures. The cultures were treated with LPS with or without Wnt3a, 2 hr prior to injury by H2O2 (0.4 mM). Wnt signaling was
measured using a luciferase reporter assay. Wnt3a increased Wnt signaling (p,0.05, n = 5, compared with H2O2 only) but preconditioning with LPS
did not induce Wnt signaling or change the level of Wnt3a-dependent Wnt signaling. Therefore, LPS-induced preconditioning is independent of the
canonical Wnt pathway. (B) The Muller glia-photoreceptor cultures were incubated with LPS with or without the Wnt pathway inhibitor Dkk1
(200 ng/ml), followed by exposure to H2O2. The protection by LPS was not altered by Dkk1, indicating that endogenous Wnt pathway activation is
not required. Mean 6 SD, n = 5, compared with PBS treated. Viability was measured by Cell Titer Blue. (C) Proposed model of regulation of
photoreceptor neuroprotection by cross-talk between the TLR4 and Wnt signaling pathways. (Left) During oxidative stress injury, TLR4 signaling
suppresses Wnt signaling at the level of LRP6 receptor activation, leading to reduced Wnt3a-mediated photoreceptor protection. (Right) In the
presence of LPS preconditioning prior to oxidative stress, activation of TLR4 reduces TNFa, leading to increased neuroprotection. TLR4 does not
regulate the Wnt signaling pathway during preconditioning.
doi:10.1371/journal.pone.0036560.g008
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TNFa suppression, prior to oxidative stress injury, is a novel
mechanism of neuroprotection for photoreceptors (Figure 8C).
Recent studies have linked dysregulation of the innate immune
system with several common diseases of the retina, including age
related macular degeneration (AMD) [72,73] and glaucoma [74].
In AMD, dysfunctional RPE are believed to trigger an in-
flammatory response [75], but the specific contribution of innate
immunity to photoreceptor death is unknown. TLR4 may be
activated by signature molecules found in AMD retinas, including
oxidized lipids, lipofuscin and components of protein deposits
known as drusen [72,76]. Once activated, TLR4 could contribute
to the pathogenesis of AMD by inducing neurotoxicity to
photoreceptors, similar to its activity elsewhere in the CNS.
TLR4 attracted considerable attention and controversy recently
because coding and non-coding polymorphisms in the TLR4 gene
were associated with AMD [77,78], although subsequent studies
only confirmed a genetic association with non-coding SNPs and
AMD [77]. Multiple TLRs are expressed in retina cell types
involved in AMD, including RPE, macrophages, Muller glia,
photoreceptors and endothelial cells [52,53] but the activity of
TLR4 has not been examined during AMD or other photorecep-
tor disease. Our data in the retinal cultures suggest that TLR4
activity in Muller glia and/or photoreceptors may contribute to
photoreceptor death in AMD. TLR4 may be stimulated in AMD
eyes by chronic low-level injury that releases DAMPs, oxidized
lipids or other tissue damage. Therefore, regulating TLR4 activity,
or the expression of endogenous damage response molecules to
prevent TLR4 activation, may be a potential therapeutic target for
retinal diseases such as AMD.
Materials and Methods
Cell Culture and Reagents
All procedures involving mice were performed in accordance
with the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research and were approved by the Animal Care and
Use Committee at the University of Miami, protocol number 10-
078. The mouse lines used were C57Bl/6 and C3H/HeOuJ (as
known as rd1) from Jackson Laboratory (Bar Harbor, Maine) and
TLR4 knock-out mice [79]. Primary Muller glia-photoreceptor
co-cultures were prepared as described in [17]. Briefly, retinas
from wild-type mice at post-natal day (P) 8 mice were dissociated
in activated papain for 30 min at 37uC, mixed with Neurobasal
medium containing 16 LoOvo plus DNAse I (Invitrogen,
Carlsbad, CA) and pelleted by low-speed centrifugation. The cell
pellet was washed in neurobasal-LoOvo medium without DNAse
and plated in neurobasal medium containing L-glutamine, B27
and antibiotics onto poly-D-lysine/laminin coated 96-well dishes
at a density of 2.56105 cells per well. Immunohistochemistry using
antibodies recognizing cell-type specific marker proteins were used
to confirm the purity of the cultures.
The human Muller glia cell line MIO-M1 was a gift from Dr.
Astrid Limb [80] and the mouse microglia cell line BV2 [81] were
generously provided by Dr. Venkata Kakulavarapu (University of
Miami). Both cell lines were maintained in Dulbecco modified
Eagle medium (DMEM) supplemented with 10% fetal bovine
serum, 1% penicillin and streptomycin and 10 mg/ml L-
glutamate. Recombinant Wnt3a and Dkk1 were obtained from
R&D Systems (Manassas, VA), ultra-pure LPS E. Coli 0111:B4
and the TLR4 antagonist LPS-RS were from Invivogen (San
Figure 9. Localization of TLR4 in photoreceptors and Muller glia by immunodetection of TLR4, rhodopsin and vimentin in wild-type
(C57Bl/6) and degenerating (C3H/HeOuJ) mouse retinas. (A,C) Both strains of mice were analyzed at post-natal day 14, which corresponds to
the peak of rod photoreceptor degeneration in C3H/HeOuJ. TLR4 (red) is expressed in photoreceptors, shown by label overlap with rhodopsin (green,
arrow) within the inner segments of C57 retinas, and in inner segments and outer nuclear layer (ONL) in C3H retinas. Sections stained with 2u
antibody only (red, Alexa 546; green, Alexa 488) were used as controls for nonspecific staining. (B,D) TLR4 is expressed in Muller glia, as shown by
label overlap of TLR4 (red) with the Muller glia protein vimentin (green). Expression of TLR4 within the Muller glia processes are clearly evident in the
inner plexiform layer (IPL). Images in A–B are 106magnification, and C–D are 206magnification, using a Zeiss confocal microscope. DAPI was used
to label the nuclei. RPE: Retinal pigmented epithelium, ONL: Outer nuclear layer, INL: Inner nuclear layer, IPL: Inner plexiform layer, GCL: Ganglion cell
layer, Scale bar, A–C 25 mm, D 12 mm.
doi:10.1371/journal.pone.0036560.g009
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Diego, CA), recombinant TNFa and soluble TNF Receptor Type
I and Type II molecules to block the receptors were from
Peprotech (Rocky Hill, NJ). Wnt3a conditioned media was
prepared from mouse L-cells stably expressing Wnt3a (ATCC,
Manassas VA), filtered and mixed with equal parts normal media
for use. The control conditioned media was prepared from
parental L-cells. The antibodies used in this study are listed in
Table 1.
Photoreceptor Viability Assays
Muller glia-photoreceptor co-cultures in triplicate wells were
treated with or without H2O2 in the presence of PBS control,
recombinant Wnt3a and/or LPS, for 24 hours. Viability was
measured using the Cell Titer Blue reagent (Promega, Madison,
WI), which was added for 1 hour at 37uC and was quantified using
an ELISA plate reader. Average absorbance measured for media
plus treatment was subtracted from each test sample. Each
experiment was performed at least three times on different days.
For the preconditioning studies, LPS was added 2 hours before the
addition of H2O2 and Wnt3a and viability was measured as above.
The two hour time-point was chosen because it is within the range
typically used in published preconditioning studies in neuronal
cultures, In some experiments, recombinant inhibitory molecules
(Wnt3a, Dkk1, TNFa and TNF Receptor Type I and Type II, see
previous paragraph) were added in addition to, or instead of, LPS,
2 hours before H2O2 treatment.
Caspase 3 activation was also used as a marker of cell death,
using the anti-active caspase 3 antibody (Cell Signaling, Danvers,
MA). The Muller glia-photoreceptor co-cultures were immunos-
tained with anti–vimentin and anti–rhodopsin antibodies to
identify caspase 3-positive cells, and counterstained with DAPI
to label the nuclei. To determine the percentage of apoptotic cells
per treatment, the total number of cells was counted, and
apoptotic cells were quantified by counting green fluorescence
caspase 3 staining that overlapped with vimentin or rhodopsin.
The cultures were counted in a masked fashion.
Quantitative PCR
Total RNA was extracted from cell pellets using Trizol reagent
(Invitrogen), according to the manufacturer’s directions as pre-
viously described [82]. One microgram of RNA was treated with
DNase (Ambion, Austin, TX) and cDNA was synthesized using
Thermoscript (Invitrogen). QPCR was performed using the
iCycler thermocycler (BioRad, Hercules, CA) with primers that
were designed to be specific to the gene of interest and were
separated by at least one intron within the gene. The primers
were: TNFR1: sense: 59 TGAGTGCGTCCCTTGCAGCCA 39,
antisense 59 CGGGCCTCCACCGGGGATATC 39; TNFR2
sense 59 CCTCGGACACCGTGTGTGCG 39, antisense 59
AAGGCGCAGTACCTGCCAGC 39; TNFa: sense 59
TCTTCTCATTCCTGCTTGTGG 39, antisense 59
CACTTGGTGGTTTGCTACGA 39; IL6: sense 59
CCAATTTCCAATGCTCTCCT 39, antisense 59 ACCACAGT-
GAGGAATGTCCA 39. Each gene was amplified in triplicate per
QPCR experiment, and each experiment was performed at least
five times on independently prepared samples. Relative transcript
levels of each gene were calculated using the delta-delta Ct method
using the house-keeping gene ARP, as described, [83]. Standard
PCR was performed using Taq polymerase (New England
Biosciences) for TLR4 using the primers: TLR4 sense 59
TTTATTCAGAGCCGTTGGTG 39, antisense 59 CAGAG-
GATTGTCCTCCCATT 39.
Western Blotting
The human Muller glia cell line MIO-M1 was treated with
Wnt3a conditioned media or control conditioned media in the
presence or absence of 50 mg/ml LPS. The cells were then
harvested and lysed in buffer containing proteinase and phospha-
tase inhibitor cocktail (50 mM Tris, pH7.4, 150 mM NaCl, 1%
NP40, 0.05% SDS). Twenty micrograms of total protein were
resolved in 10% SDS–PAGE gels using Tris-glycine buffer and the
proteins were then transferred onto polyvinylidene fluoride
(PVDF) membranes and probed using the antibodies that detect
total GSK3b, total LRP6, phospho-GSK3b at Ser9, phospho-
LRP6 at Ser1490, and b-actin, followed by several washes,
incubation with horseradish peroxidase (HRP)-conjugated second-
ary antibodies (Santa Cruz Biotechnology Inc, Santa Cruz CA),
and incubation with enhanced chemiluminescence reagent (ECL-
plus) (GE Amersham, Pistacataway NJ). The proteins were
detected with a Chemidoc imager (BioRad) and the bands were
quantified using NIH Image J. The values were normalized to b-
actin to correct for loading differences, and the relative
phosphorylation status was expressed as phospho-GSK3b/total
GSK3b and phospho-LRP6/total LRP6. The source of antibodies
and dilutions are listed in Table 1.
An antigen blocking experiment was performed to confirm the
specificity of the anti-TLR4 antibody. Briefly, 0.5 ml of antibody
was preincubated with 100 mg and 200 mg of its peptide epitope
(Santa Cruz Biotechnology Inc.) for 1 hr at room temperature.
Identical fractions of MIO-M1 cell lysates were loaded into
adjacent wells of an SDS-PAGE gel, transferred onto a PVDF
membrane, and the membrane was cut into strips. The strips were
incubated with anti-TLR4 antibody or the antibody-peptide
mixes, washed, incubated in secondary antibody, and then
assembled together for imaging, as described above.
Wnt Signaling Activity Luciferase Assays
Primary Muller glia-photoreceptor co-cultures and cell lines
were co-transfected with a 4:1 ratio of the TOP-FLASH luciferase
reporter plasmid (a generous gift from Dr. R. Moon, HHMI,
University of Washington) and a Renilla luciferase plasmid
Table 1. Antibodies used in the study.
Protein Company Dilution
TLR4 Abcam Inc 1:75 (IHC)
TLR4 Santa Cruz 1:50 (IHC), 1:1000 (W)
Iba1 Wako Chemicals 1:100 (IHC)
Active caspase 3 Cell Signaling 1:200 (IHC)
p65 Santa Cruz 1:50 (IHC)
LRP6 Cell Signaling 1:1000 (W)
p-LRP6 Cell Signaling 1:1000 (W)
GSK3b Cell Signaling 1:1000 (W)
p-GSK3b Cell Signaling 1:1000 (W)
Glutamine synthetase Sigma 1:300 (IHC)
TNFa ThermoScientific 1:100 (IHC)
b-actin sigma 1:5000 (W)
Vimentin sigma 1:300 (IHC)
rhodopsin Millipore 1:300 (IHC)
IHC, immunohistochemistry; W, Western blot.
doi:10.1371/journal.pone.0036560.t001
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(Promega) using a nucleofector electroporator (Lonza, Wakers-
ville). Wnt signaling was induced by the addition of Wnt3a at
24 hr post-transfection. The cells were harvested after 24 hr into
Reporter lysis buffer (Promega, Madison WI) [84], according to
the manufacturer’s directions. Luciferase activity was measured in
a Lumistar Galaxy luminometer (BMG Labtech Inc, Cary NC)
and normalized to Renilla activity. Wnt signaling activity is
expressed as firefly luciferase units/Renilla luciferase units. The
assays were performed in triplicate wells in at least four
independent experiments.
Immunohistochemistry
Eyes were rinsed in PBS, fixed in 4% paraformaldehyde,
incubated in increasing sucrose concentrations (5%–20%) then
embedded in OCT and flash-frozen, as described [84]. Sections
were cut at 10 mm thickness. Immunostaining of the Muller glia-
photoreceptor co-cultures was performed on cultures plated onto
glass chamber slides (Lab-Tek), as described in [17]. The retinas
and retinal culture slides were blocked in non-immune serum from
the species of the secondary antibody and incubated with primary
antibody overnight at 4uC, washed in PBS, and then incubated
with secondary antibody. The sections were counterstained with
DAPI, mounted in a solution of glycerol/PBS and were viewed
using a fluorescent microscope (Zeiss Axiovert 200), equipped with
a 206/NA 0.70 (HC Plan-Apochromat; Leica) objective lens, or
a confocal microscope (Leica TCS SP5, Leica Microsystems),
equipped with a 636/NA 1.4 oil (Plan-Apochromat; Leica)
objective lens. Image acquisition and analysis software was
Axiovision LE (Carl Zeiss) using a cooled charge-coupled device
camera or the Leica Application Suite (Leica), respectively. All
sections were imaged at room temperature (20–22uC). Photo-
graphic and microscopic settings were kept constant for compar-
isons between antibody and control staining. The images were
processed for publication using Photoshop (Adobe) with only
minimal adjustment of brightness or contrast that was applied to
the entire figure, including the positive and negative controls.
Statistical Analysis
Student’s t-test or two-way analysis of variance (ANOVA) were
used for statistical analyses using GraphPad Prism. A p-value
,0.05 was considered significant.
Supporting Information
Figure S1 IL-6 expression analysis of wild-type and
dominant-negative TLR4. IL-6 values obtained by QPCR
were normalized to the housekeeping gene ARP, and then to the
GFP transfection control (*p,0.01, n = 4). Mean 6 SD is shown.
White bars, wild-type TLR4, grey bars, dominant-negative TLR4.
(TIF)
Figure S2 Analysis of TLR4 expression in TLR4 knock-
out (TLR4 KO) retinas. Absence of TLR4 detection in Muller
glia and photoreceptors indicates specificity of the anti-TLR4
antibody. Artifactual separation of the photoreceptor outerseg-
ments is denoted by (ˆ). Images are at 206 magnification using
a Zeiss confocal microscope. DAPI was used to label the nuclei.
RPE: Retinal pigmented epithelium, ONL: Outer nuclear layer,
INL: Inner nuclear layer, IPL: Inner plexiform layer, GCL:
Ganglion cell layer. Scale bar, A–C 25 mm, D 12 mm.
(TIF)
Figure S3 Analysis of label overlap of TLR4 and
rhodopsin and TLR4 and vimentin. Confocal microscopy
imaging software was used to identify regions of label overlap of
TLR4 and the photoreceptor marker protein rhodopsin (A–D) and
the Muller glia marker protein vimentin (E–H). The merged
images (see also Fig. 9 for the images presented separately) were
analyzed and regions of label overlap are indicated in white.
Images are at 106magnification for A–C and 206 for D, using
a Zeiss confocal microscope. DAPI was used to label the nuclei.
RPE: Retinal pigmented epithelium, ONL: Outer nuclear layer,
INL: Inner nuclear layer, IPL: Inner plexiform layer, GCL:
Ganglion cell layer, Scale bar, A–C 25 mm, D 12 mm.
(TIF)
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